| Secondary |
| Hypertension |
34.9% |
| Cardiac Failure |
10.0% |
| Drug Use For Unknown Indication |
7.2% |
| Nephrotic Syndrome |
7.2% |
| Hyperuricaemia |
4.8% |
| Osteoporosis |
4.8% |
| Diabetes Mellitus |
3.8% |
| Gastritis |
3.8% |
| Hypercholesterolaemia |
3.8% |
| Hyperlipidaemia |
3.8% |
| Constipation |
1.9% |
| Dyslipidaemia |
1.9% |
| Oedema |
1.9% |
| Reflux Oesophagitis |
1.9% |
| Asthma |
1.4% |
| Bronchitis |
1.4% |
| Cardiac Failure Chronic |
1.4% |
| Pneumonia |
1.4% |
| Product Used For Unknown Indication |
1.4% |
| Angina Pectoris |
1.0% |
|
| Pancreatitis Acute |
11.4% |
| Leukopenia |
8.6% |
| Superior Sagittal Sinus Thrombosis |
8.6% |
| Toxic Epidermal Necrolysis |
8.6% |
| Cystitis |
5.7% |
| Hypertension |
5.7% |
| Platelet Count Decreased |
5.7% |
| Rash |
5.7% |
| Renal Failure |
5.7% |
| Vomiting |
5.7% |
| Azotaemia |
2.9% |
| Blood Creatinine Increased |
2.9% |
| Blood Pressure Decreased |
2.9% |
| Blood Pressure Systolic Abnormal |
2.9% |
| Dizziness |
2.9% |
| Drug Hypersensitivity |
2.9% |
| Feeling Abnormal |
2.9% |
| Hepatic Function Abnormal |
2.9% |
| Nausea |
2.9% |
| Renal Failure Acute |
2.9% |
|
| Concomitant |
| Hypertension |
40.4% |
| Diabetes Mellitus |
6.5% |
| Hyperlipidaemia |
5.1% |
| Type 2 Diabetes Mellitus |
4.6% |
| Drug Use For Unknown Indication |
4.5% |
| Insomnia |
3.9% |
| Rheumatoid Arthritis |
3.8% |
| Pustular Psoriasis |
3.6% |
| Hyperuricaemia |
3.5% |
| Cardiac Failure Chronic |
2.8% |
| Osteoporosis |
2.6% |
| Gastritis |
2.4% |
| Angina Pectoris |
2.4% |
| Constipation |
2.1% |
| Product Used For Unknown Indication |
2.1% |
| Prophylaxis |
2.1% |
| Diabetic Neuropathy |
2.0% |
| Cardiac Failure |
1.9% |
| Nephrotic Syndrome |
1.9% |
| Infection |
1.8% |
|
| Urinary Tract Infection |
10.5% |
| White Blood Cell Count Decreased |
10.5% |
| Renal Failure Acute |
5.6% |
| Interstitial Lung Disease |
4.8% |
| Rash |
4.8% |
| Renal Disorder |
4.8% |
| Renal Failure Chronic |
4.8% |
| Urticaria |
4.8% |
| Vitreous Haemorrhage |
4.8% |
| Vomiting |
4.8% |
| Anaphylactic Shock |
4.0% |
| Cerebral Infarction |
4.0% |
| Hypoglycaemia |
4.0% |
| Rhabdomyolysis |
4.0% |
| Somnolence |
4.0% |
| Subarachnoid Haemorrhage |
4.0% |
| Toxic Epidermal Necrolysis |
4.0% |
| Urinary Retention |
4.0% |
| White Blood Cell Count Increased |
4.0% |
| Cerebral Haemorrhage |
3.2% |
|
| Interacting |
| Disseminated Tuberculosis |
71.0% |
| Hypertension |
29.0% |
|
| Hypertensive Encephalopathy |
70.0% |
| Hepatic Failure |
30.0% |
|
